(Sebastian Kaulitzki/Science Photo Library/Getty Images) Pancreatic cancer is on course to be the second-leading cause of ...

Loss of an enzyme necessary for a process called lipoylation disrupts the way cancer cells copy their DNA, increasing their ...

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...

Peruvian municipalities in Satipo and Nauta have granted legal rights to native stingless bees. These tiny pollinators are ...

Faculty of Medicine in Canada have developed a new targeted cancer therapy that can precisely seek out and destroy tumor ...

Researchers have developed a dual-mechanism compound that significantly extended survival in preclinical pancreatic cancer ...

A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a ...

Structural insight into KRAS conformational cycling exposed temporary binding opportunities, overturning the “undruggable” ...

In what is said to be a 'bold modernization of clinical research,' the U.S. FDA has taken two major steps toward implementing real-time clinical trials- an approach that ...

ABU DHABI, 3rd May, 2026 (WAM) -- Sheikh Nahyan Mubarak Al Nahyan, Minister of Tolerance and Coexistence, affirmed that the United Arab Emirates, under the leadership of President His Highness Sheikh ...

NR3C1 encodes the glucocorticoid receptor (GR) and regulates stress responses, metabolism, immune function, and inflammation, ...

Reducing breast cancer mortality requires strategic health investment, stronger care pathways, multisectoral partnership and ...